Cargando…
Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin
Development of innovative more effective therapy is required for refractory osteosarcoma patients. We previously established that glycogen synthase kinase-3β (GSK- 3β) is a therapeutic target in various cancer types. In the present study, we explored the therapeutic efficacy of GSK-3β inhibition aga...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363568/ https://www.ncbi.nlm.nih.gov/pubmed/27780915 http://dx.doi.org/10.18632/oncotarget.12781 |